Skip Navigation
NIH HHS News Release Logo
National Institute of Allergy and
Infectious Diseases (NIAID)
http://www.niaid.nih.gov

FOR IMMEDIATE RELEASE
Monday, April 23, 2007

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

NIAID MEDIA AVAILABILITY
New Virus Discovered After Three Organ Transplant Recipients in Australia Succumb to Infection

WHAT:

The unfortunate deaths of three organ transplant recipients in Australia this past January has led to the discovery of a new virus. All three had received organs from the same deceased donor in December, and their closely spaced deaths suggested their transplants might have exposed them to a deadly infectious agent. When investigators at the Victorian Infectious Diseases Reference Laboratory in Melbourne applied all the standard tests, however, they could not identify any known pathogen. So the Australian team turned to scientists at the Greene Infectious Disease Laboratory of the Mailman School of Public Health of Columbia University, who have been developing new techniques for diagnosing infectious diseases with funds from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Partnering with the company 454 Life Sciences, the Columbia University team applied a high-throughput technology that can sequence hundreds of thousands of bits of DNA simultaneously. Then, using bioinformatics algorithms they had created, the team sorted through the data and identified a new infectious agent—a virus that was sufficiently different from any known virus that it could not have been detected using existing diagnostic methods. By assembling additional genetic sequences, the researchers determined that the new virus is related to, but distinct from, known strains of lymphocytic choreomeningitis virus (LCMV), which has been implicated in a small number of cases of disease transmission by organ transplantation. The knowledge of the genetic sequence of this new virus will enable improvements in screening that may enhance the future safety of organ transplantation.

BACKGROUND: The Victoria Department of Health Services in Australia announced these findings in a news conference on Sunday, April 22, 2007. The findings have not yet been published in a scientific journal. For more information, see http://hnb.dhs.vic.gov.au/web/pubaff/medrel.nsf/
LinkView/EC46161875663852CA2572C5000A1F3D?OpenDocument
and http://www.mailmanschool.org/news/display.asp?id=537.
SPOKESPERSON: NIAID Director Anthony S. Fauci, M.D., is available to comment on the discovery.
CONTACT: To schedule interviews, contact the NIAID News and Public Information Branch, (301) 402-1663 or niaidnews@niaid.nih.gov.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH...Turning Discovery Into Health ®

back to top


Last Updated April 23, 2007